Lion Biotechnologies, Inc. 4
4 · Lion Biotechnologies, Inc. · Filed Nov 7, 2013
Insider Transaction Report
Form 4
Singh Manish
DirectorPresident & CEO10% Owner
Transactions
- Award
Common Stock
2013-11-05+607,500→ 1,813,500 total - Purchase
Common Stock
2013-11-05$2.00/sh+125,000$250,000→ 1,938,500 total - Award
Warrant
2013-11-05+125,000→ 125,000 totalExercise: $2.50From: 2013-11-05Exp: 2018-11-05→ Common stock (125,000 underlying)
Footnotes (2)
- [F1]These shares were issued to the reporting person pursuant to a merger agreement between Lion Biotechnologies, Inc. and Genesis Biopharma, Inc. dated July 24, 2013 whereby upon the completion of a financing within 12 months following the merger, additional shares would be issued to the reporting person. The Issuer completed a financing on November 5, 2013.
- [F2]These warrant shares were acquired in a recent offering by the Issuer of common stock and warrants whereby a purchase of each share of common stock included a warrant exercisable for one share of common stock at $2.50 per share.